Synergistic Activity of PARP Inhibition by Talazoparib (BMN...

Clinical Cancer Research 2015 / 02 Vol. 21; Iss. 4

Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program

Smith, M. A., Reynolds, C. P., Kang, M. H., Kolb, E. A., Gorlick, R., Carol, H., Lock, R. B., Keir, S. T., Maris, J. M., Billups, C. A., Lyalin, D., Kurmasheva, R. T., Houghton, P. J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-14-2572
Date:
February, 2015
File:
PDF, 1.90 MB
english, 2015
Conversion to is in progress
Conversion to is failed